Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19

Stanford University

Status: Completed

Conditions: Coronavirus

Treatments: Other: There is no intervention

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT04373148

1U54CA260517-01 (U.S. NIH Grant/Contract)

IRB-55689

1R21ES033049-01 (U.S. NIH Grant/Contract)

2U19AI057229 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Enrollment: 316 patients

Sex: All

Ages: 2+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Adults (18 years and older) and children with confirmed COVID-19 (RT-PCR diagnosis).
• Adults (18 years and older) and children without COVID-19 for controls (who test negative for COVID-19 but may have viral symptoms)

Exclusion criteria

• Patients with special risks attendant to venipuncture will be excluded.

Trial design

316 participants in 2 patient groups

COVID-19

Description:

Participants diagnosed with COVID-19

Treatment:

Other: There is no intervention

Controls

Description:

Participants not diagnosed with COVID-19

Treatment:

Other: There is no intervention